Trane (NYSE: TT) CEO sells $23 million stake in prearranged trade

What happened

Trane Technologies plc (NYSE: TT) said Chair and CEO and director David S. Regnery sold 48,091 ordinary shares on 2026-10-06 at $480.00 each. The sale was worth about $23.08 million.

The same filing says Regnery exercised 48,091 stock options at $78.97 on the same date and reported 96,951 shares after the sale. The option shares vested in three pro rata annual installments starting on February 5, 2020. The form also marks the Rule 10b5-1 box and says the plan was adopted on May 4, 2026.

The derivative table shows 0 stock options left after the exercise. It also lists 24,500 ordinary shares held in a revocable trust, and the option grant expires on 02/04/2029.

Key numbers

Metric	Latest	Change	Source
Shares sold	48,091 shares		SEC Form 4
Sale price per share	$480.00		SEC Form 4
Total sale value	about $23.08 million		SEC Form 4
Shares held after sale	96,951 shares		SEC Form 4
Option exercise price	$78.97		SEC Form 4
Trust-held shares	24,500 ordinary shares		SEC Form 4

Read more: Trane Technologies (TT) stock analysis and investment case

Why it matters

OptimistFi's case is that Trane can compound if climate-control customers keep paying for efficient, reliable systems. This filing is mixed for that view because it shows a large insider sale, but the plan makes it a prearranged holdings update, not a fresh operating signal.

The 48,091 shares were about 33.2% of Regnery's 145,042.43-share direct holding before the sale. After the trade, the direct holding fell to 96,951.43 shares, while the 24,500 trust-held shares stayed listed separately.

The filing gives a clear before-and-after view of Regnery's direct position. It also shows the sale price of $480.00 against the $78.97 option exercise price, which makes the transaction easy to track.

The option exercise explains why the filing includes both an ordinary share sale and a derivative table entry. It also leaves 0 stock options outstanding in the table, which shows the exercise was complete.

The filing's caution is built in, since the transaction was made under a Rule 10b5-1 plan adopted on May 4, 2026. That limits how much the trade says about the operating outlook or any change in the business itself.

Browse: stock research on every company OptimistFi covers

What's next

The Rule 10b5-1 plan adopted on May 4, 2026 is the main frame for any later trades. The next SEC Form 4 would be the cleanest follow-up if more transactions come through that plan.

Those two figures are the best reference points if later filings show more activity. The 10b5-1 box and May 4 adoption date are the only schedule-like facts tied to the trade.

Until then, the filing mainly updates ownership, not operations. Investors can compare any later Form 4 with the 96,951 shares Regnery reported after this sale.

More from OptimistFi